These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23239591)

  • 21. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia.
    Budimirovic DB; Protic D
    Vojnosanit Pregl; 2016 Dec; 73(12):1089-93. PubMed ID: 29341564
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population.
    Lévesque S; Dombrowski C; Morel ML; Rehel R; Côté JS; Bussières J; Morgan K; Rousseau F
    Clin Genet; 2009 Dec; 76(6):511-23. PubMed ID: 19863547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family.
    Cortés H; Reyes-Rosales M; Rojas-Velasco AJ; García-Juárez B; Tapia-Guerrero YS; Arenas-Diaz S; Leyva-García N; Macías-Gallardo JJ; Carrillo-Mora P; Magaña JJ
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):527-531. PubMed ID: 32716213
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing the Fragile X Syndrome Newborn Screening Landscape.
    Riley C; Wheeler A
    Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
    Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
    JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
    Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
    Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a male with fragile X syndrome through newborn screening.
    Famula J; Basuta K; Gane LW; Hagerman RJ; Tassone F
    Intractable Rare Dis Res; 2015 Nov; 4(4):198-202. PubMed ID: 26668780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
    Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
    Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of
    Kumari D; Usdin K
    Expert Rev Mol Diagn; 2020 Apr; 20(4):363-365. PubMed ID: 32067539
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
    Finucane B; Lincoln S; Bailey L; Martin CL
    Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
    Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
    Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compound heterozygosity at the FMR1 gene.
    Hegde MR; Fawkner M; Chong B; McGaughran J; Gilbert D; Love DR
    Genet Test; 2001; 5(2):135-8. PubMed ID: 11551100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.
    Winarni TI; Utari A; Mundhofir FE; Tong T; Durbin-Johnson B; Faradz SM; Tassone F
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):162-6. PubMed ID: 21988366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tremor/ataxia syndrome related to Fragile X premutation].
    Sallansonnet-Froment M; De Greslan T; Roux X; Bounolleau P; Ouologuem M; Taillia H; Ricard D; Renard JL
    Presse Med; 2010 Feb; 39(2):187-95. PubMed ID: 19419833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile X syndrome: clinical presentation, pathology and treatment.
    Salcedo-Arellano MJ; Hagerman RJ; Martínez-Cerdeño V
    Gac Med Mex; 2020; 156(1):60-66. PubMed ID: 32026885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.